胎儿密度的演变和与超声波估计胎儿体重的相关性:前性研究
A Bouachba1,2,3, R Bartin3, J De Jesus Neves3
1SOFFOET, Société Française de Fœtopathologie, Paris, France.
概括
胎儿密度从怀孕16周到20周显著下降,然后在22周后稳定在1.0g/cm3左右. 这种基于MRI的测量有助于早期胎儿体重估计和检测生长异常.
科学领域:
- 产科和妇科 产科和妇科
- 胎儿医学 胎儿医学
- 医疗成像医学成像
背景情况:
- 准确的胎儿体重估计对于监测妊娠健康至关重要.
- 磁共振成像 (MRI) 提供了详细的胎儿体积 (FBV) 评估.
- 了解整个妊娠期间胎儿密度的变化是改善生长评估的关键.
研究的目的:
- 在整个妊娠期使用MRI评估胎儿密度.
- 探索胎儿密度在早期胎儿体重估计中的应用.
- 为了确定与妊娠年龄相关的胎儿密度的变化.
主要方法:
- 对196名健康孕妇 (16-36周妊娠期) 的前性研究.
- 胎儿密度计算为超声波估计胎儿体重与MRI衍生FBV的比率.
- 第三度多项式回归模拟了妊娠年龄和胎儿密度之间的非线性关系.
主要成果:
- 胎儿密度急剧下降,从16周的1.42g/cm3下降到20周的1.12g/cm3.
- 在怀孕22周后,密度稳定在约1.02g/cm3.
- 导出了一个回归方程,以模拟胎儿密度与妊娠年龄的变化.
结论:
- 胎儿密度显著下降,然后在妊娠期间稳定.
- 在22周后,MRI衍生的胎儿密度可以接近胎儿体重 (体重=体积×密度).
- 这个参数显示了早期检测胎儿生长异常和完善体重预测模型的潜力.
相关概念视频
Fetal Circulation
2.5K
Fetal circulation is a unique system that facilitates the exchange of gases, nutrients, and waste products between the developing fetus and the mother. This intricate process takes place through a special organ called the placenta.
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
2.5K
Ultrasonography
7.3K
Ultrasonography is an imaging technique that uses high-frequency sound waves to visualize the body's internal structures. It is a non-invasive and safe procedure that does not involve the use of ionizing radiation, making it widely used in various medical fields. Ultrasonography is used to study heart function, blood flow in the neck or extremities, certain conditions such as gallbladder disease, and fetal growth and development.
During an ultrasonography procedure, a handheld device called...
During an ultrasonography procedure, a handheld device called...
7.3K
Teratogenicity
3.9K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.9K


